The g factors and the ligand superhyperfine parameters A and B for Ni 3+ in KMgF3, CsCaF3 and RbCaF3 are theoretically studied from the formulas of these parameters for a 3d 7 ion under octahedral environments in the weak field scheme. The unpaired spin densities for the fluorine 2s, 2pσ and 2pπ orbitals are quantitatively determined from the molecular orbital and configuration interaction coefficients based on the cluster approach. The calculated results show good agreement with the experimental data, based on only one adjustable parameter (i.e., the proportionality factor ρ related to the ligand s-and p-orbitals). The superhyperfine parameters for the axial and planar ligands in RbCaF3:Ni 3+ are satisfactorily interpreted from the different impurity-ligand distances due to the elongation of the ligand octahedron during cubic-to-tetragonal phase transition.
The spin Hamiltonian parameters, the g factors gi (i = x, y, z) and the hyperfine structure constants Ai, and the local structure for Rh2+ in rutile (TiO2) are theoretically investigated from the perturbation formulas of these parameters for a 4d7 ion under rhombically elongated octahedra. In view of the covalency, the ligand orbital and spin-orbit coupling contributions are taken into account from the cluster approach. The planar bond angle in the impurity center is found to be 7.5° larger than that of the host Ti4+ site because of the Jahn–Teller effect via bending of the planar Rh2+-O2– bonds, leading to much smaller rhombic distortion. The theoretical spin Hamiltonian parameters based on the above Jahn–Teller angular distortion show reasonable agreement with the experimental data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.